Anthony_Loera, on 07 November 2012 - 12:48 AM, said:
I really don't know how C60 could target (or be attracted to) cancer cells or if the light could affect C60 inside cells.
The authors of the Cayce article mentioned a few different companies that were looking into this at the time the article was written, which I'm guessing was early 2000's. They mention C Sixty, Inc., which had Dr. Smalley on the Board of Directors at the time. They also mention a company named BioPhotoFullerenes, Inc., and I could only find one relevant page from 2003 about the company here.
Here is a quote:
"BioPhotoFullerenes will be developing cancer therapy applications based on the principle of photodynamic therapy, but utilizing the Fullerene molecule. Holding many patents and with a strong milestone-driven development plan, the team expressed its confidence in the prospects for the company. Initial applications will focus on skin-deep tumor therapy and other skin disease applications, according to Chen. Chiang also announced that home kit versions of skin therapy using the company's technology may be released as early as the end of this year, pending the successful search for a marketing partner."
When I get some time, I'll try to locate these patents. Or if anyone else wants to track them down, that would be great.
And lastly, there was Project 2592, titled Laser Fullerene-Oxygen Therapy that was coordinated by the International Science & Technology Center out of Russia. This project looks like it was quite an undertaking, and it was completed in 2007. The page describing the project is here.